Wellgistics Health, Inc. (WGRX)
NASDAQ: WGRX · Real-Time Price · USD
0.1320
-0.0120 (-8.33%)
At close: Apr 20, 2026, 4:00 PM EDT
0.1316
-0.0004 (-0.30%)
After-hours: Apr 20, 2026, 7:59 PM EDT
Wellgistics Health Revenue
In the year 2025, Wellgistics Health had annual revenue of $23.34M with 28.73% growth. Wellgistics Health had revenue of $1.67M in the quarter ending December 31, 2025, a decrease of -86.54%.
Revenue (ttm)
$23.34M
Revenue Growth
+28.73%
P/S Ratio
0.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.34M | 5.21M | 28.73% |
| Dec 31, 2024 | 18.13M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionWGRX News
- 6 days ago - Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives - Accesswire
- 10 days ago - Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk - Benzinga
- 4 weeks ago - Why Are Shares Of Wellgistics Health Falling? - Benzinga
- 4 weeks ago - Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders - Accesswire
- 4 weeks ago - Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share - Accesswire
- 5 weeks ago - Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction - Accesswire
- 5 weeks ago - Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities - Accesswire
- 6 weeks ago - Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM) - Accesswire